gene in patients relapsing following remedy While using the BCL2 antagonist venetoclax. sixty six Resistance to those brokers has long been related to these mutations in about 70% of instances, Though they are generally subclonal and their certain part leading to resistance should be verified.??? "???????????????????????????????????????????????"Duv… Read More